Sintx technologies announces the sale of first silicon nitride antipathogenic powder to o2today

Salt lake city, june 30, 2021 (globe newswire) -- sintx technologies, inc. (www.sintx.com) (nasdaq: sint) (“sintx” or the “company”), an original equipment manufacturer of silicon nitride ceramic for medical and non-medical applications, announced today it has moved into the next phase of its relationship with o2today and sold the first shipment of flex sn-ap antipathogenic silicon nitride powder to o2today for integration into a proprietary line of masks and filters.
SINT Ratings Summary
SINT Quant Ranking